Buyer Beware: The Danger of Purchasing Pharmaceuticals Over the Internet : Hearings Before the Permanent Subcommittee on Investigations of the Committee on Governmental Affairs, United States Senate, One Hundred Eighth Congress, Second Session, June 17 and July 22, 2004 |
Other editions - View all
Common terms and phrases
advertising agencies American approved Atorvastatin Border Protection Canada Canadian Canadian drug Canadian pharmacies CBP and FDA Celebrex Chairman CONGRESS THE LIBRARY consumers controlled substances counterfeit drugs countries credit card Crixivan Customs and Border dispensed Drug Enforcement Administration drug importation drug products drug samples exported facilities Federal FedEx foreign Internet pharmacies foreign pharmacies Giuliani Google Haight hydrocodone identified illegal importation of prescription international mail Internet sites issue labeling law enforcement licensed Lipitor look manufactured MasterCard medicines million narcotics online pharmacy operations OxyContin packages patient percent Permanent Subcommittee pharmaceuticals pharmacists physician prescription drugs problem purchased risk Ryan safety samples we received selling Senator COLEMAN Senator PRYOR SHEPHERD shipments shipped Square Trade STANA Subcommittee on Investigations targeted task force testimony Thank U.S. Postal Service U.S. residents unapproved United Viagra Vicodin Visa web crawler Websites Yahoo
Popular passages
Page 348 - GAO's Web site (www.gao.gov) contains abstracts and fulltext files of current reports and testimony and an expanding archive of older products. The Web site features a search engine to help you locate documents using key words and phrases. You can print these documents in their entirety, including charts and other graphics. Each day, GAO issues a list of newly released reports, testimony, and correspondence. GAO posts this list, known as "Today's Reports,
Page 224 - This is an issue that speaks directly to our mission. We will continue to make every effort possible to work with the Congress and our fellow inspection agencies to address the health and safety concerns of the American people.
Page 55 - Do you swear that the testimony you are about to give the subcommittee will be the truth, the whole truth, and nothing but the truth, so help you God ? Mr.
Page 247 - counterfeit drug" means a drug which, or the container or labeling of which, without authorization, bears the trademark, trade name, or other identifying mark, imprint, or device, or any likeness thereof, of a drug manufacturer, processor, packer, or distributor other than the person or persons who in fact manufactured, processed, packed, or distributed such drug and which thereby falsely purports or is represented to be the product of, or to have been packed or distributed by, such other drug manufacturer,...
Page 234 - FD&C Act, FDA has the legal authority to take action against: • The importation, sale, or distribution of an adulterated or misbranded drug; • The importation, sale, or distribution of an unapproved new drug; • Illegal promotion of a drug; • The sale or dispensing of a prescription drug without a valid prescription; and • Counterfeit drugs.
Page 381 - Chairman The Honorable John D. Dingell Ranking Minority Member Committee on Energy and Commerce House of Representatives The Honorable William M.
Page 111 - Act that any word, statement, or other information appear on the label shall not be considered to be complied with unless such word, statement, or other information also appears on the outside container or wrapper, if any there be...
Page 247 - counterfeit substance" means a controlled substance which, or the container or labeling of which, without authorization, bears the trademark, trade name, or other identifying mark, imprint, number, or device, or any likeness thereof, of a manufacturer, distributor, or dispenser other than the person or persons who in fact manufactured, distributed, or dispensed...
Page 243 - The drugs dispensed were adulterated because of the defendants' failure to follow cGMP in packaging, holding, and labeling of the drugs. The indictment alleged that during the course of the conspiracy the defendants and others generated sales in excess of $28 million that was billed to consumers as charges for prescription drugs, doctor consultations, and shipping. The indictment charges defendants with violations of the FD&C Act, as well as conspiracy, mail fraud, and money laundering. The charges...